MYFEMBREE ®: A Retrospective Cohort Study Using an Administrative Healthcare Database to Assess Pregnancy Outcomes in Women Treated With Relugolix Combination Therapy
Conditions: Pregnancy Related; Pregnancy Complications; Pregnancy, High Risk Intervention: Drug: Relugolix + Estradiol + Norethindrone Acetate Sponsor: Myovant Sciences GmbH Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials